Description

Kuwubara et al identified prognostic factors for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). These can help to identify a patient who may or may not need aggressive management. The authors are from Chiba University in Japan.


Patient selection: chronic inflammatory demyelinating polyneuropathy (CIDP).

 

Favorable outcome: complete remission

 

Unfavorable outcome: refractory to therapy or treatment dependent relapse

 

Parameter

Favorable

Unfavorable

mode of onset

subacute

chronic/insidious

symptoms

symmetrical

asymmetrical

muscle atrophy

no

yes

response to steroid therapy

yes

no

site of motor nerve conduction abnormalities

distal

intermediate nerve segments

 


To read more or access our algorithms and calculators, please log in or register.